搜索临床试验以:尼罗替尼 150mg 口服胶囊 [Tasigna]
总计1162个结果
-
Georgetown UniversityNational Institutes of Health (NIH)招聘中
-
Sichuan Provincial People's Hospital未知
-
Northwestern UniversityUniversity of Iowa; University of Rochester; Michael J. Fox Foundation for Parkinson's Research完全的
-
Chung Shan Medical UniversityGolden Biotechnology Corporation终止
-
National Taiwan University Hospital完全的
-
Hospital for Special Surgery, New YorkNovartis Pharmaceuticals; Rudolph Rupert Scleroderma Program完全的
-
Beijing Union Pharmaceutical Factory LtdR&G Pharma Studies Co.,Ltd.招聘中
-
Gruppo Italiano Trapianto di Midollo Osseo完全的
-
Seoul National University HospitalNovartis Pharmaceuticals完全的
-
Indiana UniversityNovartis完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women...完全的
-
Weill Medical College of Cornell UniversityNovartis Pharmaceuticals完全的
-
Stanford UniversityNovartis完全的淋巴瘤,非霍奇金 | 淋巴瘤,T 细胞,外周 | 骨髓移植失败美国, 加拿大
-
M.D. Anderson Cancer CenterNovartis撤销
-
Seoul St. Mary's HospitalNovartis未知
-
Klinikum Nürnberg招聘中慢性肾功能衰竭 | SGLT2 抑制和/或 MR 拮抗作用对体液和电解质稳态的机制影响德国, 法国
-
Novartis Pharmaceuticals完全的
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes...完全的
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust完全的
-
M.D. Anderson Cancer CenterArray BioPharma终止
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation完全的
-
Novartis Pharmaceuticals终止慢性粒细胞白血病 | 费城染色体阳性 (Ph+) | 低伊马替尼谷水平的慢性粒细胞白血病慢性期 (CML-CP) 患者美国
-
Massachusetts General HospitalCenter for Microbiome Informatics and Therapeutics主动,不招人
-
Novartis Pharmaceuticals终止
-
Ulsan University HospitalThe Korean Society of Hematology CML working party未知
-
King Abdullah International Medical Research CenterNovartis终止
-
University Health Network, TorontoNovartis完全的慢性期慢性粒细胞白血病 | 费城阳性急性淋巴细胞白血病 | 加速期慢性粒细胞白血病 | 母细胞期慢性粒细胞白血病 | 对酪氨酸激酶抑制剂治疗有抵抗力加拿大
-
Palobiofarma SLClínica Universidad de Navarra完全的